EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?
Bristol Myers Squibb Company (NYSE:BMY) Stock Has Average Target Price of $64.88 According to Analysts
Analysts' Recent Ratings Updates for Bristol Myers Squibb (BMY) - Stock Observer
Bristol Myers Squibb Company $BMY Stock: Assenagon Asset Management S.A. Raises Position
RBC Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
AbbVie (ABBV) Receives a Buy from RBC Capital
Bristol Myers Squibb (BMY) Heads To ESMO 2026 With New Oncology Data
Drugmakers seek to intervene in lawsuit challenging 340B pilot
AbbVie vs. Bristol Myers: Is AbbVie's Valuation Premium Worth Paying?
Microsoft 365 Copilot vs Google Gemini Enterprise: 2026 Adoption, Productivity Gains and Real-World AI Deployments
Bristol Myers is Cheaper Than Pfizer, but Its 40% Earnings Jump Has a Catch
Bristol Myers vs. Eli Lilly: Is BMY's Deep Valuation Discount Hiding an Opportunity?
Analyzing Milestone Pharmaceuticals (NASDAQ:MIST) and Bristol Myers Squibb (NYSE:BMY) - Zolmax
Rare prostate cancer histologies: detection, characteristics and treatment
USA Financial Formulas Makes New $919,000 Investment in Bristol Myers Squibb Company $BMY - Markets Daily
13,923 Shares in Bristol Myers Squibb Company $BMY Bought by USA Financial Formulas - Zolmax
Lupin Receives CDSCO Approval for Nivolumab Biosimilar in India, ETPharma
Birch Hill Investment Advisors LLC Acquires 160,411 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Newly Purchased by New England Research & Management Inc.
Bristol Myers Squibb (NYSE:BMY) Stock Moved Up to "Strong-Buy" by The Goldman Sachs Group
Bristol Myers Squibb Company $BMY Stock Bought by Howard Capital Management LLC - Daily Political
Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)
RBC Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Eli Lilly & Co (LLY) Receives a Buy from RBC Capital
RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)
RBC Capital Reaffirms Their Hold Rating on Pfizer (PFE)
Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know
Bristol Myers Squibb's Rally Has Momentum, but Can Its New Drugs Justify More Upside?
Triasima Portfolio Management inc. Purchases New Stake in Bristol Myers Squibb Company $BMY
Iams Wealth Management LLC Acquires 24,964 Shares of Bristol Myers Squibb Company $BMY
How Mixed Admilparant Results and Strong Oncology Data Will Impact Bristol Myers Squibb (BMY) Investors
Insitro's Virtual Human attracts $1.5B MASH deal with Astrazeneca
Bristol Myers Squibb Company $BMY Stock Sold by Chiron Capital Management LLC - Stock Observer
Bristol Myers Squibb Company $BMY Shares Sold by Viking Fund Management LLC
Bristol Myers Squibb Company $BMY Position Reduced by Fort Washington Investment Advisors Inc. OH
Head-To-Head Analysis: Milestone Pharmaceuticals (NASDAQ:MIST) & Bristol Myers Squibb (NYSE:BMY) - Markets Daily
65,007 Shares in Bristol Myers Squibb Company $BMY Purchased by B.A. Schrock Wealth Management Inc. - Stock Observer
14,607 Shares in Bristol Myers Squibb Company $BMY Acquired by Sanders Morris Harris LLC - Daily Political
Stock Market Movers: Best and Worst Performers of 14 October 2026
Bristol Myers Squibb (NYSE:BMY) Shares Up 4% - What's Next?
Bristol Myers Squibb Company $BMY Shares Sold by Perpetual Ltd
Bristol-Myers Squibb Company Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
Renal Cancer Clinical Trial Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire
Bristol Myers Squibb Company $BMY Shares Sold by Courier Capital LLC - Zolmax
Bristol Myers Squibb (BMY) Stock Trades At A Discount Following Its 38% Run
BlackLine Honors Global Enterprise Leaders Transforming Financial Operations
Bristol Myers Squibb (BMY) Stock May Be Undervalued Despite Fresh Phase 3 Trial Wins
Bristol Myers Squibb (NYSE:BMY) Stock Price Target Cut by Wells Fargo & Company - Daily Political
Pulmonary Fibrosis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 110+ Leading Players Wheeling the Therapeutics Landscape | ABNewswire
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Bristol-Myers Squibb (BMY) and Palvella Therapeutics (PVLA)
Health Care Up Amid Deal Activity - Health Care Roundup | Morningstar
BMY's RYZ101 Meets Phase 3 Goal, Improving PFS In Advanced GEP-NETs
Bristol Myers dips on 'confounding' lung drug results
13 New 4-Star Stocks This Week | Morningstar
Bristol Myers Squibb Reports Positive Phase 3 Results For Admilparant In IPF
Bristol-Myers Squibb Announces Positive Topline Data From RYZ101 Study, Stock Up In Pre-Market
Bristol Myers' Phase 3 Trial Of Admilparant In Idiopathic Pulmonary Fibrosis Met Primary Endpoint
Bristol Myers Squibb Treatment Meets Primary Endpoint in Phase 3 Trial for Idiopathic Pulmonary Fibrosis | Morningstar
Bristol Myers Squibb stock surges on dual phase 3 clinical trial successes
Bristol Myers cancer therapy meets main goal in late-stage study
Bristol Myers Squibb (NYSE:BMY) and Takeda Pharmaceutical (NYSE:TAK) Financial Review - Zolmax
Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint | Morningstar
NSCLC Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Merck | ABNewswire
Bristol Myers Squibb (NYSE:BMY) Stock Gets Price Target Trim from Cantor Fitzgerald - Stock Observer
Bristol Myers Squibb Company $BMY Holdings Lessened by RTD Financial Advisors Inc. - Markets Daily
20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC
Bristol Myers Squibb Company $BMY Shares Sold by RTD Financial Advisors Inc. - Stock Observer
Bank of America Cuts Bristol Myers Squibb (NYSE:BMY) Price Target to $66.00
Bristol Myers Squibb (NYSE:BMY) Stock Price Target Raised at Rothschild & Co Redburn
53,744 Bristol Myers Squibb Company $BMY Shares Sold by Douglas Lane & Associates LLC
Bristol Myers Squibb (NYSE:BMY) Stock Price Target Lowered at Bank of America - Daily Political
Bristol Myers Squibb Company $BMY Stock Bought by Monument Capital Management
Bristol Myers Squibb Company $BMY Shares Acquired by Mn Services Vermogensbeheer B.V.
11,617 Bristol Myers Squibb Company $BMY Shares Bought by Monument Capital Management - Stock Observer
Quintet Private Bank Europe S.A. Lowers Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
Bristol Myers Squibb Company $BMY Stock Sold by Quintet Private Bank Europe S.A. - Stock Observer
Bristol Myers Squibb (NYSE:BMY) Stock Price Target Lowered at Cantor Fitzgerald - Markets Daily
BMY Maintains Rating by Morgan Stanley -- Price Target Raised to
5 Dividend Stocks With Fortress-Like Coverage and Room for Things to Go Wrong
Bristol Myers Squibb (BMY) Expands CAMZYOS Approval, Is The Stock Still A Bargain?
Takeda's zasocitinib raises bar for oral psoriasis drugs
Bristol Myers Squibb (NYSE:BMY) Stock Rating Cut to Market Perform at Leerink Partners - Markets Daily
Bristol Myers (BMY) Stock is Trading Below 10 Times Forward Earnings. Here's Why it Matters - Insider Monkey
Top Pharmaceutical Stocks To Follow Now - October 5th - Markets Daily
Top Pharmaceutical Stocks To Follow Now - October 5th - Stock Observer
Pfizer's Turnaround Could Be Bigger Than Investors Think, Set For 20% Upside
Bristol Myers Squibb Deepens Commitment to Healthcare
AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?
CX Institutional Sells 208,135 Shares of Bristol Myers Squibb Company $BMY
Eli Lilly & Co (LLY) Gets a Buy from RBC Capital
BMY Stock Gets Stronger EPS Forecast from Zacks Research - Daily Political
Urine cell-free RNA for bladder cancer detection and treatment response prediction
Analysts unshaken by patient death in BMS lung fibrosis trial
BristolMyers News
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?
Is Tesla Stock a Good Buy Right Now? Earnings, AI Growth and Valuation Risks
Latest news
Show more
USD/JPY Holds Near 158 as Japan’s Trade Deficit Widens and Rate Uncertainty Persists
Netflix Stock Falls Nearly 6% After Hours as Weak Outlook Overshadows Earnings Beat
Japan and South Korea Stocks Rebound as Semiconductor Shares Lead Gains
SpaceX Stock Jumps 7.5% as AI Revenue Surges 830% and Q3 Profit Hits $4.4 Billion
Gold Price Today: XAU/USD Slips Near $4,118 as Inflation Risks Keep Fed in Focus
